Streetbeat News

XFIN

ExcelFin Acquisition Corp.

Industry

Shell Companies

ExcelFin Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in San Francisco, California.

Open

11.35

Mkt cap

61M

Volume

23K

High

11.49

P/E Ratio

-18.48

52-wk high

13.52

Low

9.03

Div yield

N/A

52-wk low

9.03

Excelfin Acquisition Corp. has received a notice of non-compliance with Nasdaq's listing rule as of September 11. This could impact its stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 4:36 pm

ExcelFin Acquisition's merger partner, Baird Medical Devices, announced that its subsidiary, Betters (Suzhou) Medical, has received FDA clearance to market its microwave ablation systems in the U.S. This regulatory approval could potentially open up a significant market for Baird Medical Devices and by extension, ExcelFin Acquisition.

Portfolio Pulse from Charles Gross

November 22, 2023 | 11:20 am

ExcelFin Acquisition Corp's shares have resumed trading.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 2:10 pm

ExcelFin Acquisition Corp shares will resume trading at 10:10 a.m. ET.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 1:57 pm

Baird Medical, a leading microwave ablation (MWA) medical device developer in China, is set to go public on NASDAQ through a business combination with ExcelFin Acquisition Corp. The combined company will have an estimated post-transaction enterprise value of $370 million and will operate as Baird Medical Investment Holdings Limited under the ticker symbol BDMD.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 1:55 pm

Shares of ExcelFin Acquisition Corp (XFIN) have been halted due to pending news.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 1:40 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.